![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, December 20, 2012 11:08:52 AM
"Thereafter, current Amarantus advisor Dr. Joseph Rubinfeld will provide his views on areas of significant commercial potential for MANF beyond Parkinson's disease."
If anyone doesn't think a partnership deal is in the works they're crazy.
We have the co-founder of Amgen presenting on the commercial potential of MANF beyond PD. He has previously stated that "MANF could be the biggest success I have ever seen". We also have senior execs from Bayer and Bristol Myers as well as a prior president of the American Medical Association Foundation on the board.
We have Hermo Pharma, a MJFF grant recipient and VC backed bio tech firm, that felt compelled to challenge the company's MANF patents because they cause undue burden on anyone trying to test it (i.e., they will have to go through AMBS if they want to) and lost.
We have a drug that has shown significantly better results than another drug that at the same exact stage it is at was bought for $250 Million.
I completely understand why people want to take profits. Do you want to listen to college kids bash the stock like ALL-IN or golong or do you want to listen to the co-founder of Amgen or the president of the American Medical Association Foundation or an executive from Bayer all say how MANF could be a huge success?
The ones that can hold through the ups and downs will make out like bandits with this company.
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM